ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director

November 26, 1993

Grant Supplements, and Challenge Grants

February 20, 2009

How Much Is Life Worth? The $440 Billion Question

July 31, 2009